;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Capnia amends IPO

    Capnia Inc., Redwood City, Calif. Business: Neurology, Inflammation Date announced: 2014-08-25 Type: IPO To be raised: $11.1 million Shares: 1.7 million Price: $6.50 Underwriters: Maxim Group; National Securities; …

    Published on 9/1/2014
  • 20/20 GeneSystems completes venture financing

    20/20 GeneSystems Inc., Rockville, Md. Business: Diagnostic Date completed: 2014-08-18 Type: Venture financing Raised: Not disclosed Investor: Bao Hao Investment Management Note: The amount raised was not disclosed.

    Published on 9/1/2014
  • Aldea Pharmaceuticals completes venture financing

    Aldea Pharmaceuticals Inc., Redwood City, Calif. Business: Cardiovascular Date completed: 2014-08-25 Type: Venture financing Raised: $24 million Investors: RusnanoMedInvest; WuXi Corporate Venture Fund; Canaan Partners;…

    Published on 9/1/2014
  • Armetheon completes venture financing

    Armetheon Inc., Menlo Park, Calif. Business: Cardiovascular, Infectious Date completed: 2014-08-28 Type: Venture financing Raised: $7 million Investors: AshHill Biomedical Investments; Hercules Bioventures; Atheneos …

    Published on 9/1/2014
  • Bellicum completes venture financing

    Bellicum Pharmaceuticals Inc., Houston, Texas Business: Cancer Date completed: 2014-08-27 Type: Venture financing Raised: $55 million Investors: RA Capital Management; Perceptive Advisors; Jennison Associates; Sabby …

    Published on 9/1/2014
  • Bioniche completes follow-on

    Bioniche Life Sciences Inc. (TSX:BNC), Belleville, Ontario Business: Cancer, Agbio/Environmental Date completed: 2014-08-22 Type: Follow-on Raised: C$5 million ($4.6 million) Shares: 21.8 million Price: C$0.23 (unit) …

    Published on 9/1/2014
  • Civitas completes venture financing

    Civitas Therapeutics Inc., Chelsea, Mass. Business: Drug delivery, Neurology, Pulmonary Date completed: 2014-08-25 Type: Venture financing Raised: $55 million Investors: Adage Capital Management; OrbiMed Advisors; …

    Published on 9/1/2014
  • DelMar Pharma completes warrant exercise

    DelMar Pharmaceuticals Inc. (OTCBB:DMPI), Vancouver, B.C. Business: Cancer Date completed: 2014-08-08 Type: Warrant exercise Raised: $495,448 Shares: 762,227 Price: $0.65 Shares after offering: 29.7 million Investor: …

    Published on 9/1/2014
  • Dermira completes venture financing

    Dermira Inc., Redwood City, Calif. Business: Dermatology Date completed: 2014-08-19 Type: Venture financing Raised: $51 million Placement agent: Leerink Partners Investors: Bay City Capital; New Enterprise Associates; …

    Published on 9/1/2014
  • diaDexus completes debt financing

    diaDexus Inc. (OTCBB:DDXS), South San Francisco, Calif. Business: Diagnostic Date completed: 2014-08-18 Type: Debt financing Raised: $15 million Investor: Oxford Finance Note: The senior secured loan bears 6.95% …

    Published on 9/1/2014
  • Durata Therapeutics completes debt financing

    Durata Therapeutics Inc. (NASDAQ:DRTX), Chicago, Ill. Business: Infectious Date completed: 2014-05-27 Type: Debt financing Raised: $15 million Investor: PDL BioPharma Inc. Note: Durata raised $15 million in the second …

    Published on 9/1/2014
  • Emisphere completes debt financing

    Emisphere Technologies Inc. (OTCBB:EMIS), Cedar Knolls, N.J. Business: Drug delivery Date completed: 2014-08-20 Type: Debt financing Raised: $5 million Investor: MHR Fund Management LLC Note: Emisphere drew down $5 …

    Published on 9/1/2014
  • FortuneRock completes venture financing

    FortuneRock Ltd., Beijing, China Business: Cancer, Inflammation, Infectious Date completed: 2014-08-25 Type: Venture financing Raised: RMB145 million ($23.6 million) Investors: Jinhua Pharmaceutical Co. Ltd.; and other …

    Published on 9/1/2014
  • GenoSpace completes venture financing

    GenoSpace LLC, Cambridge, Mass. Business: Bioinformatics Date completed: 2014-08-12 Type: Venture financing Raised: $5 million Investor: Thomson Reuters Note: The company raised $5 million in an undisclosed venture …

    Published on 9/1/2014
  • Heat Biologics completes debt financing

    Heat Biologics Inc. (NASDAQ:HTBX), Chapel Hill, N.C. Business: Cancer, Inflammation, Infectious Date completed: 2014-08-25 Type: Debt financing Raised: $1.5 million Investor: Square 1 Bank Note: Heat Biologics drew down…

    Published on 9/1/2014
  • Immunovaccine completes follow-on

    Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 2014-08-26 Type: Follow-on Raised: C$8.7 million ($8 million) Units: 9.2 million Price: C$0.95 (unit) Shares after …

    Published on 9/1/2014
  • Immunovaccine completes private placement

    Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 2014-08-26 Type: Private placement Raised: C$2 million ($1.8 million) Shares: 2.2 million Price: C$0.90 Shares after …

    Published on 9/1/2014
  • Microbix completes private placement of units

    Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario Business: Generics, Infectious, Supply/Service Date completed: 2014-08-22 Type: Private placement of units Raised: C$1.2 million ($1.1 million) Units: 3.1 million…

    Published on 9/1/2014
  • NeoGenomics completes follow-on

    NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Genomics, Diagnostic, Supply/Service Date completed: 2014-08-15 Type: Follow-on Raised: $37 million Shares: 8.1 million Price: $4.60 Shares after offering: 58.1 …

    Published on 9/1/2014
  • NeuroDerm completes venture financing

    NeuroDerm Ltd., Ness Ziona, Israel Business: Neurology, Drug delivery Date completed: 2014-08-21 Type: Venture financing Raised: $16 million Investors: Elias Group; existing investors; new investors

    Published on 9/1/2014
  • Nirmidas Biotech completes venture financing

    Nirmidas Biotech Inc., San Francisco, Calif. Business: Diagnostic Date completed: 2014-08-18 Type: Venture financing Raised: $2 million Investors: Stanford StartX Fund; angel investor; and an undisclosed investor

    Published on 9/1/2014
  • Northwest Biotherapeutics completes private placement of convertible notes

    Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md. Business: Cancer Date completed: 2014-08-14 Type: Private placement of convertible notes Raised: $17.5 million Shares outstanding prior: 59.5 million Note: The…

    Published on 9/1/2014
  • OncoPep completes venture financing

    OncoPep Inc., North Andover, Mass. Business: Cancer Date completed: 2014-08-28 Type: Venture financing Raised: $6.9 million Investors: Leukemia & Lymphoma Society; angel investors; individual investors; existing …

    Published on 9/1/2014
  • Orexo completes private placement

    Orexo AB (SSE:ORX; OTCQX:ORXOY), Uppsala, Sweden Business: Neurology, Inflammation, Drug delivery Date completed: 2014-08-29 Type: Private placement Raised: SEK346.5 million ($50.6 million) Shares: 2.5 million Price: …

    Published on 9/1/2014
  • Prosensa completes private placement of convertible notes

    Prosensa Holding N.V. (NASDAQ:RNA), Leiden, the Netherlands Business: Musculoskeletal, Neurology Date completed: 2014-08-11 Type: Private placement of convertible notes Raised: EUR500,000 ($669,250) Shares outstanding …

    Published on 9/1/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993